Enabling Screening for All
We are the pioneer in portable eye screening technologies. Our handheld imaging devices and AI services help to improve access to eye screening for blinding eye diseases.Read more
Optomed since 2004
We were established 20 years ago, with the goal of improving the accessibility and efficiency of eye screenings, particularly in primary healthcare settings.
Optomed’s Financial Statements Bulletin 2023 is now published.
The number of diabetics has been growing rapidly around the world and one third of them suffer from diabetic retinopathy, the most common cause of vision loss in working-age adults.
Diabetic retinopathy is treatable, if detected early. However, due to the limited number of ophthalmologists and eye screening services, majority of diabetics globally do not have access to regular screenings.
Our solution to a global problem
Effective eye screening prevents diabetes-related blindness and reduces overall health care costs.
We develop innovative and affordable solutions to enable eye screening for all patients worldwide.